Research Directory

The EU Transparency Directive: Further debate on market access

Read more

Value-based drug pricing coming soon in UK

Read more

Managers ignore pharmacovigilance at their peril

Read more

Adaptive licensing: A new approach for drug approvals

Read more

IMI: As Big Pharma pulls back, IMI steps in

Read more

MRC Technology: Going global for local returns

Read more

EU Transparency Directive: changes afoot on pricing and reimbursement

Read more

How to strengthen the biopharma ecosystem

Read more

Planning for the Unified Patent Court

Read more

An analysis of accelerated approval for cancer drugs

Read more